- Home
- CDTX vs RCON Comparison
CDTX vs RCON Comparison
Compare CDTX & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- RCON
- Stock Information
- Founded
- CDTX 2012
- RCON 2007
- Country
- CDTX United States
- RCON China
- Employees
- CDTX N/A
- RCON N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- RCON Oilfield Services/Equipment
- Sector
- CDTX Health Care
- RCON Energy
- Exchange
- CDTX Nasdaq
- RCON Nasdaq
- Market Cap
- CDTX 79.3M
- RCON 82.6M
- IPO Year
- CDTX 2015
- RCON 2009
- Fundamental
- Price
- CDTX $14.37
- RCON $2.02
- Analyst Decision
- CDTX Strong Buy
- RCON
- Analyst Count
- CDTX 5
- RCON 0
- Target Price
- CDTX $30.50
- RCON N/A
- AVG Volume (30 Days)
- CDTX 21.1K
- RCON 17.0K
- Earning Date
- CDTX 11-07-2024
- RCON 06-28-2024
- Dividend Yield
- CDTX N/A
- RCON N/A
- EPS Growth
- CDTX N/A
- RCON N/A
- EPS
- CDTX N/A
- RCON N/A
- Revenue
- CDTX $44,653,000.00
- RCON $9,475,055.00
- Revenue This Year
- CDTX N/A
- RCON N/A
- Revenue Next Year
- CDTX N/A
- RCON $15.18
- P/E Ratio
- CDTX N/A
- RCON N/A
- Revenue Growth
- CDTX 19.60
- RCON 2.59
- 52 Week Low
- CDTX $10.00
- RCON $1.26
- 52 Week High
- CDTX $24.40
- RCON $5.58
- Technical
- Relative Strength Index (RSI)
- CDTX 72.85
- RCON 31.70
- Support Level
- CDTX $12.89
- RCON $2.40
- Resistance Level
- CDTX $13.78
- RCON $2.80
- Average True Range (ATR)
- CDTX 0.70
- RCON 0.29
- MACD
- CDTX 0.13
- RCON -0.06
- Stochastic Oscillator
- CDTX 75.31
- RCON 0.00
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in the sale of oilfield automation products, equipment for oil and gas production and transportation, and engineering services. It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. Majority of the firm's revenue comes from the Automation Product and Software segment.